ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 332421 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 332421; 2) Community: the network communities that were significantly associated with the response to NSC 332421; 3) Molecule: the relationships between components within communities and NSC 332421; 4) MDR: the compounds that were significantly associated with the NSC 332421.

NSC Compound Enrichment Correlation
NSC 711175 Null 0.0102077332082016 0.2318315
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.0102077332082016 0.39193194
NSC 736493 Indenoisoquinoline derivative 0.0102077332082016 0.02472224
NSC 747174 Null 0.0102077332082016 0.25620606
NSC 758682 ARTENIMOL 0.0102077332082016 0.36603018
NSC 109451 Null 0.0102077332082017 -0.10762503
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0102077332082017 0.37680528
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0102077332082017 -0.049356135
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0102077332082017 0.32754762
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0102077332082017 0.40166433
Total:144  Current:46    [First] [Prev] [Next] [Last]